CD30 CAR for CD30+ NSGCT

Clinical trial NCT05634785 · COMPLETED

Trial details

NCT number: NCT05634785
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor Nonseminomatous Germ Cell Tumor

Start date: 2022-12-09
Primary completion: 2025-12-16
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.